Every article, report, and earnings note where MEDP appears.
4 articles
Medpace Holdings, Inc. (MEDP) jumps after-hours after posting a strong Q2 2026 earnings beat, higher revenue, and improved bookings. The CRO also raised full-year revenue guidance, signaling healthy demand and reinforcing its premium growth profile.
Medpace is still delivering strong revenue, margin, and cash flow growth, but softer bookings and a rich valuation keep the stock in Hold territory. The business quality is high, yet the current setup looks better on pullbacks than at full price.
Medpace Holdings, Inc. (MEDP) slumps after hours despite a strong first quarter, as investors focus on weaker bookings and a sub-1.0x book-to-bill ratio. The company beat on revenue and earnings, but concerns about future demand and backlog growth drove the sharp selloff.
Medpace Holdings, Inc. (MEDP) slumps nearly 19% after hours after a Q1 earnings beat failed to impress investors. Strong revenue and EPS were overshadowed by softer bookings and guidance that did not raise expectations enough for a premium-valued CRO.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate MEDP Report